实用肝脏病杂志 ›› 2026, Vol. 29 ›› Issue (5): 773-776.doi: 10.3969/j.issn.1672-5069.2026.05.034

• 胆石症 • 上一篇    下一篇

内镜下鼻胆管引流联合ERCP/EST治疗胆总管结石合并中重度急性胆管炎患者疗效研究*

祝平, 朱佳, 李晓飞, 魏源, 卢西雅   

  1. 110000 辽宁省沈阳市 辽宁省肿瘤医院内镜科(祝平,朱佳,魏源,卢西雅);锦州医科大学附属第一医院消化内科(李晓飞)
  • 收稿日期:2025-12-21 发布日期:2026-09-14
  • 通讯作者: 魏源,E-mail:drweiyuan@163.com
  • 作者简介:祝平,女,42岁,医学博士,主治医师。E-mail:sunyijun0513@163.com
  • 基金资助:
    辽宁省科技厅科学技术研究计划项目(编号:2022-BS-061)

Efficacy of endoscopic nasobiliary drainage in combination with ERCP/EST in the treatment of patients with common bile duct stones and moderate-to-severe acute cholangitis

Zhu Ping, Zhu Jia, Li Xiaofei, et al   

  1. Center of Endoscopy, Provincial Tumor Hospital, Shenyang 110000, Liaoning Province,China
  • Received:2025-12-21 Published:2026-09-14

摘要: 目的 探讨采用内镜下鼻胆管引流(ENBD)联合经内镜逆行胰胆管造影(ERCP)/内镜下乳头括约肌切开术(EST)治疗胆总管结石合并中重度急性胆管炎患者的效果。方法 2023年1月~2025年1月我院诊治的胆总管结石合并中重度急性胆管炎患者63例,被分成对照组31例和观察组32例,分别采取ERCP/EST治疗或ENBD联合ERCP/EST治疗,随访6个月。采用荧光免疫层析法检测血清降钙素原(PCT)和C反应蛋白(CRP)水平。结果 观察组术后下床活动时间和住院日分别为(16.5±3.5)h和(5.1±1.6)d,显著短于对照组【分别为(25.4±4.2)h和(7.3±2.1)d,P<0.05】;两组结石完全清除率无显著性差异(93.8%对93.5%,P>0.05);在术后3 d,观察组血清TBIL、ALT和AST水平分别为(15.8±3.8)μmol/L、(88.6±10.5)U/L和(71.4±7.6)U/L,均显著低于对照组【分别为(33.5±6.5)μmol/L、(112.5±14.2)U/L和(97.5±8.9)U/L,P<0.05】,而血清ALB水平为(37.2±6.1)g/L,显著高于对照组【(34.1±5.9)g/L,P<0.05】;观察组WBC计数、血清PCT和CRP水平分别为(10.5±2.4)×109/L、(1.0±0.5)ng/mL和(42.8±5.9)mg/L,均显著低于对照组【分别为(12.2±2.8)×109/L、(2.8±0.6)ng/mL和(65.4±7.2)mg/L,P<0.05】;随访6个月,观察组并发症发生率为12.5%,与对照组的12.9%比,无显著性差异(P>0.05)。结论 采取ENBD联合ERCP/EST治疗胆总管结石合并中重度急性胆管炎患者可促进术后恢复,改善肝功能指标,缓解炎症反应,安全性好。

关键词: 胆总管结石, 急性胆管炎, 内镜下鼻胆管引流, 经内镜逆行胰胆管造影, 内镜下乳头括约肌切开术, 治疗

Abstract: Objective The aim of this study was to investigate the efficacy of endoscopic nasobiliary drainage (ENBD) in combination with endoscopic retrograde cholangiopancreatography (ERCP)/endoscopic sphincterotomy (EST) in the treatment of patients with common bile duct stones (CBDS) and moderate-to-severe acute cholangitis (AC). Methods 63 patients with CBDS complicated with moderate-to-severe AC were enrolled in our hospital between January 2023 and January 2025, and were randomly assigned to underwent ERCP/EST in 31 cases in control, or underwent ENBD in combination with ERCP/EST in another 32 cases in observation. All patients were followed-up for six months. Serum procalcitonin (PCT) and C-reactive protein (CRP) levels were determined by fluorescence immunochromatography. Results After surgery, ambulation and hospital stay in the observation were (16.5±3.5)h and (5.1±1.6)d, both much shorter than [(25.4±4.2)h and (7.3±2.1)d, respectively, P<0.05] in the control; there was no significant difference as respect to complete stone clearance(93.8% vs. 93.5%, P>0.05); by three days after operation, serum bilirubin, ALT and AST levels in the observation group were (15.8±3.8)μmol/L, (88.6±10.5)U/L and (71.4±7.6)U/L, all significantly lower than [(33.5±6.5)μmol/L, (112.5±14.2)U/L and (97.5±8.9)U/L, respectively, P<0.05], while serum albumin level was (37.2±6.1)g/L, significantly higher than [(34.1±5.9)g/L, P<0.05] in the control; WBC count, serum PCT and CRP levels were (10.5±2.4)×109/L, (1.0±0.5)ng/mL and (42.8±5.9)mg/L, all much lower than [(12.2±2.8)×109/L, (2.8±0.6)ng/mL and (65.4±7.2)mg/L, respectively, P<0.05] in the control; by end of six-month follow-up, incidence of adverse effects in the two groups was not significant different (12.5% vs. 12.9%, P>0.05). Conclusion ERCP/EST plus ENBD is efficacious in dealing with patients with CBDS and AC, with rapid improvement of postoperative recovery.

Key words: Common bile duct stones, Acute cholangitis, Endoscopic nasobiliary drainage, Endoscopic retrograde cholangiopancreatography, Endoscopic sphincterotomy, Therapy